If you attended the live event and would like to receive credit please log in.
|
|
Type:
|
Seminar
|
|
|
Date(s):
|
07/12/10
|
|
Times:
|
6:00 PM - 8:00 PM MT
|
|
Facility:
|
Marriott |
| |
Colorado Springs , CO
|
|
Contact(s):
|
ProCE Staff
630-540-2848
info@proce.com
|
|
Fee:
|
No Charge!
|
| Course Category: |
This activity has been designated as Knowledge-Based
|
|
Live CE Information
|
Colorado Neurological Institute Presents...
|
|
Courses Offered
|
Parkinson's Disease Treatment: Key Information for Pharmacists (July 12, 2010 - Colorado Springs, CO)
|
Details:
Program Location
Marriott
5580 Tech Center Drive
Colorado Springs, CO
Program Agenda
6:00 PM Registration
6:30 PM Dinner
7:00 PM CE Presentation
8:00 PM Adjourn
Learning Objectives
The target audience for this program is pharmacists. At the completion of this program, the participant will be able to:
- List 3 cardinal features and common non-motor features of Parkinson's disease
- Explain the basic pathology, epidemiology, and natural history of Parkinson's disease
- Compare and contrast the efficacy and safety of dopamine agonists, levodopa, COMT inhibitors, and monoamine oxidase inhibitors
- Describe the motor complications associated with levodopa
- Define the concept of neuroprotection in Parkinson's disease
Faculty
Rajeev Kumar, MD
Medical Director
Movement Disorders Center
Colorado Neurological Institute
Englewood, CO
Funding
This program is supported by an educational grant from TEVA Neuroscience.
Faculty Disclosure
It is the policy of ProCE to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer of any commercial product(s) discussed in an educational presentation. Dr. Kumar has disclosed that he has received grant or research support from Abbott, the National Institutes of Health, Neurosearch, and Novartis; and has served as a speaker or consultant for Allergan, Boehringer-Ingelheim, GlaxoSmithKline, Ipsen, Medtronic, and TEVA Neuroscience.
Please note: The opinions expressed in this program should not be construed as those of the CE provider or TEVA Neuroscience. The information and views are those of the faculty through clinical practice and knowledge of the professional literature. Portions of this program may include the use of drugs for unlabeled indications. Use of drugs outside of labeling should be considered experimental and participants are advised to consult prescribing information and professional literature.
Accreditation
ProCE, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 221-999-10-026-L01-P has been assigned to this live knowledge-based program (initial release date 07-12-10). This program is approved for 1.0 contact hour (0.10 CEU) in states that recognize ACPE providers. The program is provided at no cost to participants. Statements of credit will be issued online at www.ProCE.com upon successful completion of the program evaluation. Participants must complete a program evaluation to receive pharmacy CE credit. No partial credit will be given.
ACPE - Pharmacists Accreditation
|
| Credit Hours: 1 |
Expiration Date: 07/12/2011 |
ACPE UPN: 0221-999-10-026-L01-P |
| |
Release Date: 07/12/2010
|
|
ProCE, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
|
|
To receive CE credit, participants must complete an online evaluation form for each session attended. After completing the evaluation, you can view, print and track your CE statements of credit online.
There is no fee to participate in this activity.
|
|
The material presented here does not reflect the views of Pharmacy Choice, Inc., RxSchool, or the companies providing educational content. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.
|
